Lyell Immunopharma, Inc. Company Information
Lyell Immunopharma, Inc.'s employee growth, exchange listings and data sources
Key Information
- Name: Lyell Immunopharma, Inc.
- Ticker: LYEL
- Exchange: NasdaqGS
- Founded: 2018
- Industry: Biotechnology
- Sector: Pharmaceuticals & Biotech
- Market Cap: US$614.398m
- Shares Outstanding: 254.94m
- Website: https://lyell.com
Number of Employees
Location
- Lyell Immunopharma, Inc.
- 201 Haskins Way
- South San Francisco
- California
- 94080
- United States
Listings
Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
---|---|---|---|---|---|---|
LYEL | NasdaqGS (Nasdaq Global Select) | Yes | Common Shares | US | USD | Jun 2021 |
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/04/23 00:00 |
End of Day Share Price | 2024/04/23 00:00 |
Earnings | 2023/12/31 |
Annual Earnings | 2023/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.